Policy | Funding | Influence
Insights for changemakers on navigating government opportunities.
Bioscience Bulletin
The shutdown that began on October 1 continues with no end in sight. Most Congressional Democrats refuse to support a bill to re-open the government without an extension of the Affordable Care Act subsidies, which is supported by 78% of the public according to polling by KFF.
Updates on FY25 Budget
We wanted to provide an update on recent developments in Washington around the FY25 budget and Trump Administration actions.
What’s at Stake in the Election
Before leaving DC on September 27, Congress focused on bills that reinforce party messaging, which they believe will resonate with their base, while avoiding issues that could alienate their voters and put their candidates in contentious positions.
2nd Annual Government Biotechnology Innovation Summit
G2G attended the Second Annual Government Biotechnology Innovation Summit from September 4-5
Final TCET Rulemaking
The TCET program is focused on (1) facilitating early, predictable, and safer beneficiary access to new technologies; (2) reducing uncertainty about coverage by evaluating early the potential benefits and harms of technologies with manufacturers; and (3) encouraging evidence development if notable evidence gaps exist for coverage purposes.
MHSRS 2024 DAILY DIGEST – DAY 3
On Day 3 of MHSRS, breakout sessions continued with emphasis on a range of military medical priorities.
